Bruker Corporation (BRKR)

Currency in USD
48.02
-0.75(-1.54%)
Closed·
48.020.00(0.00%)
·
BRKR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
47.5448.45
52 wk Range
28.5364.64
Key Statistics
Prev. Close
48.77
Open
48.45
Day's Range
47.54-48.45
52 wk Range
28.53-64.64
Volume
1.49M
Average Volume (3m)
2.84M
1-Year Change
-16.33%
Book Value / Share
16.03
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BRKR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
51.79
Upside
+7.84%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Bruker Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper platform for bacterial and fungal identification and establish, DNA test strips, and; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was founded in 1960 and is headquartered in Billerica, Massachusetts.

Bruker Corporation Earnings Call Summary for Q3/2025

  • Bruker reported Q3 2025 EPS of $0.45, exceeding forecasts by 36.36%, despite revenue declining 0.5% YoY to $860.5 million; stock fell 2.05% pre-market to $38.25.
  • The company set FY2025 revenue guidance at $3.41-3.44 billion with non-GAAP EPS of $1.85-1.90, projecting double-digit EPS growth and margin expansion for 2026.
  • Organic revenue declined 4.5% YoY while non-GAAP operating margin fell 260 basis points to 12.3%, highlighting operational challenges despite the earnings beat.
  • CEO Frank Laukien expects 'significant improvements in organic revenue performance' following 2025's decline, with new product launches in spatial biology signaling future growth.
  • Cost-saving initiatives are underway to drive profitability improvements, though restructuring charges may impact short-term financials amid uncertain market conditions.
Last Updated: 03/11/2025, 15:04
Read Full Transcript

Compare BRKR to Peers and Sector

Metrics to compare
BRKR
Peers
Sector
Relationship
P/E Ratio
−307.9x23.4x−0.6x
PEG Ratio
2.861.270.00
Price/Book
3.0x2.8x2.6x
Price / LTM Sales
2.1x2.5x3.2x
Upside (Analyst Target)
14.5%0.0%41.8%
Fair Value Upside
Unlock0.6%5.1%Unlock

Analyst Ratings

9 Buy
5 Hold
1 Sell
Ratings:
15 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 51.79
(+7.84% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
JPMorgan
Buy55.00+14.54%50.00Maintain15/12/2025
Wells Fargo
Buy55.00+14.54%48.00Maintain15/12/2025
Barclays
Buy55.00+14.54%45.00Maintain15/12/2025
Leerink Partners
Buy75.00+56.18%-Maintain10/12/2025
Wolfe Research
Buy60.00+24.95%-Upgrade10/12/2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.16%
Dividend Yield
0.42%
Industry Median 1.41%
Annualised payout
0.20
Paid quarterly
5-Years Growth
+4.56%
Growth Streak

Earnings

Latest Release
Nov 03, 2025
EPS / Forecast
0.45 / 0.33
Revenue / Forecast
860.50M / 847.00M
EPS Revisions
Last 90 days

Bruker (BRKR) Income Statement & Profits

People Also Watch

27.67
OLMA
-1.81%
16.81
DNLI
-3.78%
35.240
LQDA
-1.51%
20.47
OLN
-1.11%

FAQ

What Is the Bruker (BRKR) Share Price Today?

The live Bruker share price today is 48.02

What Stock Exchange Does Bruker (BRKR) Trade On?

Bruker is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Bruker?

The stock symbol (also called a 'ticker') for Bruker is "BRKR."

Does Bruker Pay Dividends? What’s The Current BRKR Dividend Yield?

Yes, BRKR Pays Dividends to its Shareholders. The current Bruker dividend yield is 0.42%.

What Is the Current Bruker Market Cap?

As of today, Bruker market capitalisation is 7.30B.

What Is Bruker's (BRKR) Earnings Per Share (TTM)?

The Bruker EPS is currently -0.16 (Trailing Twelve Months).

When Is the Next Bruker Earnings Date?

Bruker's next earnings report will be released on 17 Feb 2026.

Is BRKR a Buy or Sell From a Technical Analyst Perspective?

Based on today's Bruker moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Bruker Stock Split?

Bruker has split 0 times. (See the BRKR stock split history page for full effective split date and price information.)

How Many Employees Does Bruker Have?

Bruker has 11396 employees.

What is the current trading status of Bruker (BRKR)?

As of 24 Dec 2025, Bruker (BRKR) is trading at a price of 48.02, with a previous close of 48.77. The stock has fluctuated within a day range of 47.54 to 48.45, while its 52-week range spans from 28.53 to 64.64.

What Is Bruker (BRKR) Price Target According to Analysts?

The average 12-month price target for Bruker is USD51.78571, with a high estimate of USD75 and a low estimate of USD40. 9 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +7.84% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.